Biocryst Pharmaceuticals (BCRX) Receivables: 2010-2015
Historic Receivables for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to $7.5 million.
- Biocryst Pharmaceuticals' Receivables rose 131.47% to $7.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $21.2 million, marking a year-over-year increase of 122.81%. This contributed to the annual value of $3.8 million for FY2014, which is 81.99% up from last year.
- Per Biocryst Pharmaceuticals' latest filing, its Receivables stood at $7.5 million for Q3 2015, which was up 74.46% from $4.3 million recorded in Q2 2015.
- Biocryst Pharmaceuticals' 5-year Receivables high stood at $16.0 million for Q2 2011, and its period low was $897,000 during Q2 2014.
- Over the past 3 years, Biocryst Pharmaceuticals' median Receivables value was $3.8 million (recorded in 2014), while the average stood at $4.2 million.
- Its Receivables has fluctuated over the past 5 years, first crashed by 79.86% in 2013, then skyrocketed by 378.93% in 2015.
- Over the past 5 years, Biocryst Pharmaceuticals' Receivables (Quarterly) stood at $11.7 million in 2011, then fell by 21.76% to $9.1 million in 2012, then crashed by 76.82% to $2.1 million in 2013, then skyrocketed by 81.99% to $3.8 million in 2014, then soared by 131.47% to $7.5 million in 2015.
- Its last three reported values are $7.5 million in Q3 2015, $4.3 million for Q2 2015, and $5.6 million during Q1 2015.